• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Quality Control and Regulatory

National Survey Finds Stable Adverse Transfusion Reaction Rate in the U.S.

The 2017 National Blood Collection and Utilization Survey (NBCUS) used a web-based survey of approximately 3,000 U.S. community-based and hospital-based…

March 11, 2020

Electronic Scanning of Patient Wristbands Reduces Chance of ABO-Incompatible Transfusions

ABO-incompatible transfusions can be life-threatening to patients and are often attributable to human errors. Wrong blood in tube (WBIT) errors…

December 19, 2018

Revisiting Zika virus screening for donated blood

In 2015, the Zika virus (ZIKV) rapidly spread to the Americas and other countries, and four possible transfusion-transmission cases were…

May 10, 2018

Secondary Bacterial Culture for Platelets Reduces Transfusion Risk and Complies with FDA Draft Guidance for Platelet Safety

Platelets are most susceptible to bacterial contamination due to their storage conditions. In order to decrease the risk of bacterial…

April 4, 2018

Cost Effectiveness of Platelets Treated with Pathogen Reduction Compared to Secondary Testing

In March of 2016 the FDA introduced draft guidelines recommending additional precautions to prevent bacterial contamination in platelets. Since both…

October 4, 2017

High-Throughput Sequencing Used To Identify Pathogens in Donated Blood

Ensuring a safe blood supply requires multiple strategies and is continually evolving with new, emerging pathogens.  Researchers in Switzerland recently…

May 24, 2017

Zika-Positive Blood Donations Can Be Inactivated Using Pathogen Inactivation Technologies

Emerging infections, such as the Zika virus (ZIKV), continue to surface due to global travel, migration, and the spread of…

February 15, 2017

Transfusion Testing Strategies for Multiple Myeloma Patients Undergoing Anti-CD38 Therapy

Anti-CD38 therapies such as daratumumab have increased survival time for patients with multiple myeloma.  This novel therapy, however, interferes with…

February 10, 2017

Laboratory Testing is Suggested Before Intravenous Immunoglobulin is Given to Neonates

Although intravenous immunoglobulin (IVIG) use is documented to treat a wide range of severe disorders in adults, IVIG use in…

November 9, 2016

Massive Transfusion Protocols Vary Among U.S. Hospitals

Over the past several years, clinical studies have shown that blood transfused early and quickly can reduce mortality in severe…

October 19, 2016

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Go to Next Page »

Primary Sidebar

Latest News

  • Directed Blood Donations Should be Limited

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley